The influence of rebamipide eyedrops towards the glutathione contents of the conjunctival epithelial cells

Trial Profile

The influence of rebamipide eyedrops towards the glutathione contents of the conjunctival epithelial cells

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 19 May 2016

At a glance

  • Drugs Rebamipide (Primary)
  • Indications Dry eyes
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top